<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27834076</article-id>
      <article-id pub-id-type="pmc">5107629</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2017.37.1.92</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Genetics</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acromicric Dysplasia Caused by a Novel Heterozygous Mutation of <italic>FBN1</italic> and Effects of Growth Hormone Treatment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Hyung Suk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Ho young</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Sung Yoon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ki</surname>
            <given-names>Chang-Seok</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Song Hyun</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Ok-Hwa</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Su Jin</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Green Cross Laboratories, Yongin, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Laboratory Medicine &amp; Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <aff id="A5"><label>5</label>Department of Radiology, Woorisoa Children's Hospital, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Su Jin Kim. Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine, 55, Hwasu-ro 14 beon-gil, Deogyang-gu, Goyang 10475, Korea. Tel: +82-31-820-5421, Fax: +82-31-969-0500, <email>sjkim0128@mjh.or.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <volume>37</volume>
      <issue>1</issue>
      <fpage>92</fpage>
      <lpage>94</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Acromicric dysplasia (AD, MIM 102370) is a rare skeletal dysplasia characterized by severe short stature, short hands and feet, normal intelligence, and mild facial dysmorphism [<xref rid="B1" ref-type="bibr">1</xref>]. The radiological manifestations of AD include delayed bone age, cone-shaped epiphyses, internal notch of the femoral head, short metacarpals, and short phalanges [<xref rid="B2" ref-type="bibr">2</xref>]. Recently, missense mutations clustered in exons 41 and 42 in the transforming growth factor-&#x3B2; binding-protein-like domain 5 (TB5) of <italic>FBN1</italic> were identified as causative mutations for AD [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref>]. Here, we present the clinical and radiographic findings and effects of recombinant human growth hormone (rhGH) treatment for 3.5 yr in a child with AD, which was confirmed by identification of a novel mutation in <italic>FBN1</italic>.</p>
    <p>The patient was born to non-consanguineous parents after an uneventful 37 weeks of gestation, with a birth weight of 3,700 g. The patient was referred to our clinic with suspected skeletal dysplasia, at 11 yr of age. He presented short stature, short and stubby hands and feet, normal intelligence, and mild facial dysmorphism: round face, long eyelashes, flat nose with anteverted nostrils, prominent philtrum, and thick lips. He had a bilateral elbow flexion deformity with mild extension limitation. Skeletal survey showed mild brachymetacarpy, delayed bone age (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), and acetabular dysplasia (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). He showed marked growth retardation from 2 yr of age. At 10 yr, his height was 118.1 cm (-3.21 standard deviation score [SDS]); he was diagnosed as having partial growth hormone deficiency at another hospital, and has been treated with rhGH (0.1 IU/kg/day) since then. Subsequently, his growth velocity improved by 5.4 cm/yr, with a height gain of 0.98 SD (<xref ref-type="fig" rid="F2">Fig. 2</xref>). There were no considerable adverse effects during rhGH treatment. Considering the clinical and radiographic findings, AD was the putative diagnosis. We conducted whole-exome sequencing (WES) to simultaneously investigate multiple genes associated with skeletal dysplasia. Written informed consent was obtained from the parents of the patient, and the Institutional Review Board approved this study (IRB file number: 2012-05-080-006). Genomic DNA was extracted from peripheral blood, by using TruSeq Exome Library Prep Kit (Illumina, San Diego, CA, USA) according to the manufacturer's protocols. On the basis of the previously generated BAM file, variants were called using Samtools, smatools mpileup, bcftools view, and vcfutils.pl's varFilter with the maximum depth '-D' set to 1,000, and single nucleotide polymorphism (SNP) and short indel candidates were detected. ANNOVAR (ver. November 2011) was used to annotate these variants with dbSNP135 and the 1,000 Genomes Project SNPs. The variants were further annotated with dbSNP135Common in the UCSC database to identify those with allele frequencies &#x2265;1%, as well as those classified SCS (Clinical Significance), CLN (Variant is Clinical), and the OMIM ID from NCBI dbSNP135, using an in-house program. The WES results identified a heterozygous variant, c.5282C&gt;T (p.Thr1761Ile), in the TB5 domain of <italic>FBN1</italic> (NM_000138.4), which was validated by Sanger sequencing. The parents did not carry this variant. All reported mutations in AD are clustered in the same region encoding the TB5 domain of <italic>FBN1</italic> [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref><xref rid="B4" ref-type="bibr">4</xref>].</p>
    <p>This variant is considered pathogenic for the following reasons: First, Thr1761 in <italic>FBN1</italic> is evolutionarily well conserved in mammals. Second, in PolyPhen-2 prediction (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), p.Thr1761Ile from c.5282C&gt;T was predicted as "probably damaging" with a score of 0.999. Furthermore, this is a de novo variant, as it was not identified in either parent. AD belongs to the group of acromelic dysplasia, including geleophysic dysplasia (GD) and Weill&#x2013;Marchesani syndrome (WMS) [<xref rid="B5" ref-type="bibr">5</xref>]. In contrast to the genetic heterogeneity of GD and WMS [<xref rid="B3" ref-type="bibr">3</xref><xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref>], AD seems to be caused only by mutations in <italic>FBN1</italic>. GD is characterized by characteristic "happy" facial features, hepatomegaly, progressive cardiac disease with valvular abnormality, and tracheal stenosis, often leading to death before 5 yr of age [<xref rid="B8" ref-type="bibr">8</xref>]. WMS is distinguished from AD by eye anomalies, including lenticular myopia, ectopia lentis, glaucoma, and spherophakia [<xref rid="B9" ref-type="bibr">9</xref>]. Our patient did not show hepatomegaly, valvular heart disease, or ocular disease. He presented with a relatively mild clinical course compared with that of GD or WMS.</p>
    <p>GH treatment has not been widely applied in patients with skeletal dysplasia, because genetic heterogeneity and/or clinical variability poses a challenge for assessing the treatment efficacy [<xref rid="B10" ref-type="bibr">10</xref>]. rhGH treatment has been reported in only one case of AD, but did not show a significant effect on final height [<xref rid="B1" ref-type="bibr">1</xref>]. Our patient received rhGH treatment at 0.1 IU/kg/day for 3.5 yr. During the treatment period, his growth velocity was maintained at up to 5 cm/year, and his height SDS after 3.5 yr was -2.23 SDS. However, long-term follow-up is needed to verify the effects of rhGH treatment.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faivre</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Le Merrer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baumann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chatelain</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sulmont</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritance</article-title>
          <source>J Med Genet</source>
          <year>2001</year>
          <volume>38</volume>
          <fpage>745</fpage>
          <lpage>749</lpage>
          <pub-id pub-id-type="pmid">11694546</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Goff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mahaut</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Allali</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Abhyankar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the TGF&#x3B2; binding-protein-like domain 5 of <italic>FBN1</italic> are responsible for acromicric and geleophysic dysplasias</article-title>
          <source>Am J Hum Genet</source>
          <year>2011</year>
          <volume>89</volume>
          <fpage>7</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">21683322</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cain</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>McGovern</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kielty</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e48634</fpage>
          <pub-id pub-id-type="pmid">23133647</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Three novel mutations of the <italic>FBN1</italic> gene in Chinese children with acromelic dysplasia</article-title>
          <source>J Hum Genet</source>
          <year>2014</year>
          <volume>59</volume>
          <fpage>563</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="pmid">25142510</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Superti-Furga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Nosology and classification of genetic skeletal disorders: 2006 revision</article-title>
          <source>Am J Med Genet A</source>
          <year>2007</year>
          <volume>143A</volume>
          <fpage>1</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">17120245</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Goff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Morice-Picard</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dagoneau</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Perrot</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>YJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>ADAMTSL2</italic> mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation</article-title>
          <source>Nat Genet</source>
          <year>2008</year>
          <volume>40</volume>
          <fpage>1119</fpage>
          <lpage>1123</lpage>
          <pub-id pub-id-type="pmid">18677313</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faivre</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gorlin</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Wirtz</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Godfrey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dagoneau</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Samples</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome</article-title>
          <source>J Med Genet</source>
          <year>2003</year>
          <volume>40</volume>
          <fpage>34</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">12525539</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Goff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cormier-Daire</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Genetic and molecular aspects of acromelic dysplasia</article-title>
          <source>Pediatr Endocrinol Rev</source>
          <year>2009</year>
          <volume>6</volume>
          <fpage>418</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="pmid">19396027</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faivre</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dollfus</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lyonnet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Alembik</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>M&#xE9;garban&#xE9;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Samples</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome</article-title>
          <source>Am J Med Genet A</source>
          <year>2003</year>
          <volume>123A</volume>
          <fpage>204</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="pmid">14598350</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagen&#xE4;s</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hertel</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children</article-title>
          <source>Horm Res</source>
          <year>2003</year>
          <volume>60</volume>
          <issue>S3</issue>
          <fpage>65</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">14671400</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Radiographs of the patient with acromicric dysplasia. (A) Both hands at 11 yr of age show delayed carpal bone age, estimated to around 8 yr of age. (B) Pelvis shows small iliac bone with flat and shallow acetabuli and coxa valga of the femora.</title>
      </caption>
      <graphic xlink:href="alm-37-92-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Growth chart of the patient. Growth retardation was remarkable, and after growth hormone (GH) treatment, growth velocity increased to 5.4 cm/year.</title>
      </caption>
      <graphic xlink:href="alm-37-92-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
